Video
Author(s):
Mark Becker, the CEO of Vivacare, discusses how health care professionals can counsel patients on eczema treatment and care so they can help to deter patients from googling their symptoms and developing what can be termed “medical anxiety.”
In a Pharmacy Times® interview, Mark Becker, MD, the CEO of Vivacare, discussed how health care professionals can counsel patients on eczema treatment and care so they can help to deter patients from googling their symptoms and developing what can be termed “medical anxiety.”
He mentioned how eczema diagnosed, what the current treatment options are, and who is most likely to be affected by atopic dermatitis.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Donanemab-Azbt Receives FDA Label Update With New Dosing for Alzheimer Disease